Results 151 to 160 of about 7,960 (193)

Zinc, type 2 diabetes, diabetic kidney disease: focus on hypoxia. [PDF]

open access: yesFront Endocrinol (Lausanne)
Lebedeva SA   +6 more
europepmc   +1 more source

Pharmacological inhibition of SPAK-NKCC1 complex attenuates astrogliosis and restores cerebral blood flow in a mouse model of VCID. [PDF]

open access: yesActa Neuropathol Commun
Habib K   +12 more
europepmc   +1 more source

Efficacy of bumetanide for cognitive improvement in children and adolescents with Down syndrome: study protocol of a randomised, double-blind, placebo-controlled trial. [PDF]

open access: yesBMJ Open
Costanzo F   +17 more
europepmc   +1 more source

Sleep deprivation impairs information processing via dysregulation of chloride homeostasis in the prefrontal cortex

open access: yes
Frau R   +18 more
europepmc   +1 more source

CNS pharmacology of NKCC1 inhibitors [PDF]

open access: yesNeuropharmacology, 2022
The Na-K-2Cl cotransporter NKCC1 and the neuron-specific K-Cl cotransporter KCC2 are considered attractive CNS drug targets because altered neuronal chloride regulation and consequent effects on GABAergic signaling have been implicated in numerous CNS disorders.
Wolfgang Loscher, Kai Kaila
exaly   +6 more sources

Increased NKCC1 expression in refractory human epilepsy

open access: yesEpilepsy Research, 2007
Cation-chloride co-transporters (CCTs), particularly NKCC1, may be important in epileptogenesis. We have performed a detailed histological examination of NKCC1 in large samples of patients with hippocampal sclerosis (HS) or focal cortical dysplasia (FCD), pathologies both commonly associated with pharmacoresistant epilepsy.
Maria Thom   +2 more
exaly   +4 more sources

Home - About - Disclaimer - Privacy